3 ms·
It would still require that the company that develops the cure could make more profit off it than it would make with chronic treatments. No it doesn't. Why?
by refurb 9y ago
It would still require that the company that develops the cure could make more profit off it than it would make with chronic treatments.
No it doesn't. Why? Because there are multiple companies.
If company X is making $10B per year on a poor treatment, there is still an incentive for another company to create a cure, even if it only makes them $1B.
- croon 9y agoNo, there's an incentive for another company to make a treatment and only make $9B(/y).